Paraquat dichloride is one of the most widely used herbicides in American agriculture — and one of the most actively litigated products in the country’s current mass tort docket. Thousands of farmers, farm workers, and people who lived near treated fields are pursuing claims alleging that paraquat exposure caused their Parkinson’s disease. The scientific case for that connection has grown substantially over the past decade, and the litigation in federal court is at a consequential stage.
What Is Paraquat and Where Does Exposure Occur?
Paraquat dichloride is a broad-spectrum herbicide used primarily in agriculture to kill weeds and grasses before or between crop growth. It is one of the fastest-acting herbicides in commercial use and is widely applied to corn, soybean, cotton, wheat, and other commodity crops. In the United States, it is sold under brand names including Gramoxone, Firestorm, and Blanco.
Unlike many other countries — paraquat is banned or severely restricted in the European Union, Brazil, China, and many other nations — the United States continues to permit its use, though it requires a certified applicator license. Exposure occurs through several pathways:
- Occupational exposure. Licensed applicators, farm workers who apply or work in treated fields, and agricultural employees who handle paraquat concentrate face the highest exposure levels. Dermal contact, inhalation of spray drift, and accidental ingestion are the primary routes.
- Residential proximity. People who live near fields where paraquat is regularly applied may be exposed through drift during application, contaminated well water, and soil contact.
- Mixing and loading. Workers who mix concentrated paraquat before application face particularly high exposure because concentrate is more toxic than diluted spray.
The Scientific Link Between Paraquat and Parkinson’s Disease
The connection between paraquat exposure and Parkinson’s disease has been studied extensively since the 1980s and is now supported by substantial epidemiological evidence:
- The National Institutes of Health Agricultural Health Study — one of the largest studies of pesticide exposure and health outcomes ever conducted — found a statistically significant association between paraquat exposure and Parkinson’s disease.
- Paraquat’s chemical mechanism of action involves the generation of reactive oxygen species that damage mitochondria and dopaminergic neurons — the same neurons whose degeneration produces Parkinson’s disease.
- Numerous peer-reviewed meta-analyses have concluded that paraquat exposure is associated with an approximately 2-fold increase in Parkinson’s disease risk.
- Animal studies have consistently reproduced Parkinson’s-like neurological damage in laboratory models exposed to paraquat.
The EPA conducted a review of paraquat registration and acknowledged the emerging evidence linking it to Parkinson’s disease, though it has not moved to cancel the registration. The gap between the scientific evidence and the regulatory response is one of the central arguments in the current litigation.
The Paraquat Parkinson’s Disease Litigation
Thousands of Parkinson’s disease patients who were exposed to paraquat have filed federal lawsuits against Syngenta AG and Chevron U.S.A. — the primary manufacturer and historical U.S. distributor of paraquat products. These cases have been consolidated in a multidistrict litigation (MDL No. 3004) in the U.S. District Court for the Southern District of Illinois.
The core allegation is that Syngenta and Chevron knew for decades that paraquat exposure was associated with Parkinson’s disease, failed to adequately warn applicators and workers of that risk, and continued marketing the product without reformulation or disclosure despite internal research supporting the connection.
The litigation is at an advanced stage with bellwether cases selected to test the liability theories and damages arguments across different exposure profiles. The defendants have challenged both general causation (whether paraquat can cause Parkinson’s) and specific causation (whether each plaintiff’s Parkinson’s was caused by their individual exposure), leading to significant expert witness battles and Daubert motions that have shaped the litigation’s trajectory.
Who May Have a Paraquat Parkinson’s Disease Claim
A viable paraquat claim generally requires:
- A Parkinson’s disease diagnosis. The disease must be clinically diagnosed by a neurologist. Early Parkinson’s symptoms — tremor, rigidity, bradykinesia, postural instability — that don’t yet meet diagnostic criteria may still support a claim in development.
- Paraquat exposure history. Work as a licensed applicator, farm worker, or agricultural employee with documented or reconstructable exposure to paraquat-brand herbicides. Residential proximity to regularly treated fields is also potentially actionable, though occupational cases have the strongest exposure documentation.
- Timing relationship. The exposure must predate the Parkinson’s diagnosis. Most cases involve decades of repeated occupational exposure followed by Parkinson’s onset in middle or later life — consistent with the known latency period for environmentally induced neurodegeneration.
What a Paraquat Lawyer Does
Paraquat cases require mass tort litigation expertise similar to other pharmaceutical and agricultural chemical MDL cases:
- Developing the exposure history — obtaining employment records, pesticide purchase records, license and application records, and other documentation that reconstructs the plaintiff’s paraquat contact over time
- Coordinating with neurological experts who can document the Parkinson’s diagnosis, its severity, and its functional impact
- Working within the MDL structure through the plaintiff leadership committee to benefit from collective discovery and bellwether case development
- Evaluating whether individual case facts support general causation arguments and specific causation under the developing MDL evidentiary framework
The pharmaceutical injury lawyer guide covers the mass tort and MDL litigation framework in more detail — the same bellwether process that shapes paraquat settlement discussions applies across the mass tort landscape. For cases producing catastrophic neurological disability, a catastrophic injury attorney ensures the lifetime care costs, lost earning capacity, and ongoing disability are fully developed alongside the liability case. The product liability lawyer guide covers the broader framework for defective product claims including agricultural chemicals.
Frequently Asked Questions
Can I still file a paraquat lawsuit if I was exposed years ago?
Potentially yes. Statutes of limitations for paraquat Parkinson’s claims typically run from when you knew or reasonably should have known that your Parkinson’s disease might be connected to paraquat exposure — not simply from the date of the original exposure. Because the scientific link between paraquat and Parkinson’s has only been widely established relatively recently, the discovery rule may extend the filing period for many potential claimants. Consult an attorney promptly to evaluate the applicable limitations period for your state and circumstances.
Does paraquat still require a license to apply in the United States?
Yes. Paraquat is classified as a Restricted Use Pesticide (RUP) by the EPA, which means it can only be purchased and applied by certified applicators. This certification requirement exists because of paraquat’s acute toxicity — even a small amount can be fatal if ingested. However, the certification requirement does not protect against the long-term neurological risks associated with chronic low-level occupational exposure, which is the basis of the Parkinson’s disease litigation.
Are there any settlements yet in the paraquat Parkinson’s MDL?
As of late 2026, the paraquat MDL remains in active litigation with bellwether trials underway or scheduled. No global settlement has been announced for the federal MDL, though individual cases may have resolved confidentially. The bellwether trial outcomes and the court’s rulings on expert causation testimony will heavily influence whether and when a global settlement framework develops. An attorney can advise on the current status of the litigation and whether joining now versus waiting is strategically optimal for individual circumstances.
